RxDoctor Payments DataLook up a doctor →

Sogroya: payments to doctors

Payments that named Sogroya as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1.2M
Providers
1,453
Transactions
5,161
Average per transaction
$238

The per-transaction average — $238 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,453 providers the average total is $844, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk$1,161,67694.7%
Novo Nordisk Health Care AG$55,9824.6%
Novo Nordisk AS$9,2000.7%
← All drugs & devices